MCID: MCR011
MIFTS: 46

Microinvasive Gastric Cancer

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Microinvasive Gastric Cancer

MalaCards integrated aliases for Microinvasive Gastric Cancer:

Name: Microinvasive Gastric Cancer 12 15
Early Gastric Cancer 12 55 15 73
Surface Gastric Cancer 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10541
NCIt 50 C27131
UMLS 73 C0349530

Summaries for Microinvasive Gastric Cancer

MalaCards based summary : Microinvasive Gastric Cancer, also known as early gastric cancer, is related to gastric cancer and tubular adenocarcinoma, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Microinvasive Gastric Cancer is TDRG1 (Testis Development Related 1), and among its related pathways/superpathways is Gastric cancer. The drugs Rabeprazole and Ticlopidine have been mentioned in the context of this disorder. Affiliated tissues include lymph node, liver and colon, and related phenotypes are digestive/alimentary and neoplasm

Related Diseases for Microinvasive Gastric Cancer

Diseases related to Microinvasive Gastric Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 186)
# Related Disease Score Top Affiliating Genes
1 gastric cancer 31.2 XIST VEGFC TDRG1 MUC2 MLH1 CDX2
2 tubular adenocarcinoma 30.0 MUC2 CDX2 CDH1
3 papillary adenocarcinoma 29.9 CDH1 MUC2
4 peptic esophagitis 29.8 ATP12A ATP4A
5 pseudomyxoma peritonei 29.7 CDX2 MUC2
6 hernia, hiatus 29.7 ATP12A ATP4A
7 mucinous adenocarcinoma 29.7 MUC2 MLH1 CDX2
8 cholangiocarcinoma 29.5 CDH1 CDX2 MUC2 VEGFC
9 esophageal varix 29.4 ATP12A ATP4A
10 gastric lymphoma 29.4 ATP12A ATP4A
11 esophageal cancer 29.3 BCYRN1 CDH1 CDX2 VEGFC XIST
12 gastric adenocarcinoma 29.2 VEGFC MUC2 MLH1 CDX2 CDH1
13 adenocarcinoma 10.2
14 adenoma 10.2
15 gastric diffuse adenocarcinoma 10.2 CDH1 CDX2
16 mucinous intrahepatic cholangiocarcinoma 10.2 CDX2 MUC2
17 gastric signet ring cell adenocarcinoma 10.2 CDH1 CDX2
18 duodenum adenocarcinoma 10.2 CDX2 MUC2
19 diversion colitis 10.2 CDH1 MUC2
20 gastritis 10.2
21 degos 'en cocarde' erythrokeratoderma 10.2
22 ovarian mucinous adenocarcinoma 10.2 CDX2 MUC2
23 adenosquamous colon carcinoma 10.2 CDX2 MLH1
24 appendix disease 10.2 CDX2 MUC2
25 chronic cholangitis 10.2 CDX2 MUC2
26 small intestine adenocarcinoma 10.2 MLH1 MUC2
27 ampulla of vater adenocarcinoma 10.2 CDX2 MUC2
28 biliary papillomatosis 10.2 CDX2 MUC2
29 ovarian mucinous neoplasm 10.2 CDX2 MUC2
30 appendix cancer 10.2 CDX2 MUC2
31 cystic teratoma 10.1 CDX2 MUC2
32 biliary tract neoplasm 10.1 CDX2 MUC2
33 duodenum cancer 10.1 CDX2 MUC2
34 tongue disease 10.1 CDH1 VEGFC
35 hidradenocarcinoma 10.1 CDX2 MUC2
36 lymphoma 10.1
37 situs inversus 10.1
38 signet ring cell adenocarcinoma 10.1 MUC2 CDX2 CDH1
39 bronchiolo-alveolar adenocarcinoma 10.1 CDH1 CDX2 MUC2
40 cecum adenocarcinoma 10.1 CDX2 MLH1
41 intrahepatic cholangiocarcinoma 10.1 CDH1 CDX2 MUC2
42 gastric tubular adenocarcinoma 10.1 CDX2 MUC2
43 tongue cancer 10.1 BCYRN1 CDH1 VEGFC
44 pancreas adenocarcinoma 10.1 CDH1 CDX2 MUC2
45 colonic disease 10.1 CDH1 CDX2 MLH1
46 cystitis cystica 10.1 CDX2 MUC2
47 liver cirrhosis 10.1
48 dextrocardia with situs inversus 10.1
49 ampulla of vater cancer 10.1 CDX2 MUC2
50 intestinal benign neoplasm 10.1 CDX2 MLH1 MUC2

Graphical network of the top 20 diseases related to Microinvasive Gastric Cancer:



Diseases related to Microinvasive Gastric Cancer

Symptoms & Phenotypes for Microinvasive Gastric Cancer

UMLS symptoms related to Microinvasive Gastric Cancer:


abdominal pain, dyspepsia

MGI Mouse Phenotypes related to Microinvasive Gastric Cancer:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.43 ATP12A ATP4A CDH1 CDX2 MLH1 MUC2
2 neoplasm MP:0002006 9.02 ATP4A CDH1 CDX2 MLH1 MUC2

Drugs & Therapeutics for Microinvasive Gastric Cancer

Drugs for Microinvasive Gastric Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 122)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Rabeprazole Approved, Investigational Phase 4,Phase 3 117976-89-3 5029
2
Ticlopidine Approved Phase 4 55142-85-3 5472
3
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
4
Pantoprazole Approved Phase 4,Not Applicable 102625-70-7 4679
5
Clopidogrel Approved Phase 4 113665-84-2, 120202-66-6 60606
6
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
7
Ecabet Investigational Phase 4 86408-72-2, 33159-27-2 65781
8 Antacids Phase 4,Phase 3,Not Applicable
9 Anti-Ulcer Agents Phase 4,Phase 3,Not Applicable
10 Proton Pump Inhibitors Phase 4,Phase 3,Not Applicable
11 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
12 Platelet Aggregation Inhibitors Phase 4
13 Purinergic P2 Receptor Antagonists Phase 4
14 Analgesics Phase 4,Phase 3,Phase 2,Not Applicable
15 Analgesics, Non-Narcotic Phase 4,Not Applicable
16 Cytochrome P-450 CYP2C19 Inhibitors Phase 4
17 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
18 Fibrinolytic Agents Phase 4
19 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
20 Anti-Inflammatory Agents, Non-Steroidal Phase 4
21 Antirheumatic Agents Phase 4
22 Antipyretics Phase 4
23 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
24 Purinergic P2Y Receptor Antagonists Phase 4
25 Cyclooxygenase Inhibitors Phase 4
26 Anti-Inflammatory Agents Phase 4,Not Applicable
27 Protective Agents Phase 4,Not Applicable
28
protease inhibitors Phase 4,Not Applicable
29 Anti-Infective Agents Phase 4,Phase 3
30 HIV Protease Inhibitors Phase 4,Not Applicable
31 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
32 Anesthetics Phase 4,Phase 3,Not Applicable
33 Anticonvulsants Phase 4
34 Anti-Arrhythmia Agents Phase 4
35 calcium channel blockers Phase 4
36 Calcium, Dietary Phase 4
37 Tocolytic Agents Phase 4
38
Meperidine Approved Phase 3 57-42-1 4058
39
Midazolam Approved, Illicit Phase 3,Not Applicable 59467-70-8 4192
40
Menthol Approved Phase 3 2216-51-5 16666
41
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613
42
Clarithromycin Approved Phase 3 81103-11-9 84029
43
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
44 GABA Agents Phase 3,Not Applicable
45 GABA Modulators Phase 3,Not Applicable
46 Analgesics, Opioid Phase 3,Not Applicable
47 Anti-Anxiety Agents Phase 3,Not Applicable
48 Psychotropic Drugs Phase 3,Not Applicable
49 Narcotics Phase 3,Not Applicable
50 Tranquilizing Agents Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 88)
# Name Status NCT ID Phase Drugs
1 Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Unknown status NCT02638584 Phase 4 Ilaprazole;Rabeprazole
2 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
3 Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection Unknown status NCT01308177 Phase 4 Ecabet
4 The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study Completed NCT02235246 Phase 4 Magnesium Sulfate;Normal saline
5 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Unknown status NCT01157598 Phase 3
6 Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients Unknown status NCT02246153 Phase 3
7 Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) Unknown status NCT01609309 Phase 3
8 Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301) Completed NCT00546468 Phase 3
9 Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy Completed NCT01411176 Phase 3 Menthol;Placebo
10 Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases Completed NCT02219529 Phase 3
11 Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy Recruiting NCT02595086 Phase 3
12 A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer Recruiting NCT02748551 Phase 3
13 Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy Active, not recruiting NCT01804998 Phase 3
14 Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD Active, not recruiting NCT02407119 Phase 3 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin;Placebo, Omeprazole or Rabeprazole, Clarithromycin
15 Phase II Study for Robot Assisted Distal Gastrectomy Unknown status NCT01504997 Phase 2
16 The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric Unknown status NCT02694081 Phase 2
17 The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer Completed NCT02347956 Phase 1, Phase 2
18 Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy Completed NCT02522598 Phase 2 VVZ-149 injections;Placebo
19 Laparoscopic Gastrectomy for Advanced Gastric Cancer Completed NCT01441336 Phase 2
20 Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients Recruiting NCT02644148 Phase 2
21 Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma Recruiting NCT03814759 Phase 2 TS-1 + cisplatin
22 Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients Recruiting NCT03564834 Phase 2
23 The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer Unknown status NCT02710838 Not Applicable
24 Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer Unknown status NCT01659632
25 the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer Unknown status NCT02385578 Not Applicable
26 Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer Unknown status NCT01832246
27 Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection Unknown status NCT02189226 Not Applicable
28 Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer Unknown status NCT01132469 Not Applicable
29 Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection Unknown status NCT02037399 Not Applicable intravenous dexamethasone;intravenous normal saline
30 Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection Unknown status NCT02090062
31 Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer Unknown status NCT01774266
32 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Unknown status NCT01813994 Not Applicable Arm1: Statin;Arm2: Placebo
33 The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer Unknown status NCT02243618 Not Applicable Polaprezinc;Rebamipide
34 The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population Unknown status NCT01490541
35 Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With Diabetes Mellitus Unknown status NCT01375738 Not Applicable
36 Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC Unknown status NCT01283893
37 Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer Unknown status NCT01742806 Not Applicable
38 Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial Unknown status NCT01179724 Not Applicable high dose proton pump inhibitor;H2RB
39 PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma Unknown status NCT02515721 Not Applicable
40 The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM) Unknown status NCT01491724
41 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
42 Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients Completed NCT01643811
43 Endoscopic Submucosal Dissection Versus Gastrectomy Completed NCT02216110
44 Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer Completed NCT01544413 Not Applicable
45 Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy Completed NCT00851305 Not Applicable
46 Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer Completed NCT01943253 Not Applicable
47 Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB Completed NCT02738294 Not Applicable
48 Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer Completed NCT01617876
49 Endoscopic Submucosal Dissection (ESD)- Master Slave Robotic System - Human Study Completed NCT01394861 Early Phase 1
50 Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring Completed NCT01921283 Not Applicable no- BIS sensor attachment

Search NIH Clinical Center for Microinvasive Gastric Cancer

Genetic Tests for Microinvasive Gastric Cancer

Anatomical Context for Microinvasive Gastric Cancer

MalaCards organs/tissues related to Microinvasive Gastric Cancer:

41
Lymph Node, Liver, Colon, Bone, Spleen, B Cells, Small Intestine

Publications for Microinvasive Gastric Cancer

Articles related to Microinvasive Gastric Cancer:

(show top 50) (show all 1158)
# Title Authors Year
1
A method of detecting two tumor markers (p-hydroxybenzoic acid and p-cresol) in human urine using a porous magnetic <beta>-cyclodextrine polymer as solid phase extractant, an alternative for early gastric cancer diagnosis. ( 30262042 )
2019
2
Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen. ( 29977284 )
2018
3
Endoscopic submucosal dissection of early gastric cancer via inverted overtube in a patient with situs inversus totalis: a case report. ( 29756022 )
2018
4
Long-term outcomes after noncurative endoscopic resection ofA early gastric cancer: the optimal time for additional endoscopicA treatment. ( 29031882 )
2018
5
The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: aA systematic review of the literature and meta-analysis. ( 28966062 )
2018
6
The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer. ( 28484889 )
2018
7
Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer. ( 29330205 )
2018
8
Serial intermediate-term quality of life comparison after endoscopic submucosal dissection versus surgery in early gastric cancer patients. ( 29067581 )
2018
9
Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissection. ( 28840337 )
2018
10
Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component. ( 30228922 )
2018
11
Nonhealing gastric ulcer: progression from gastric adenoma to early gastric cancer over 9 years. ( 30176228 )
2018
12
Anthracosilicosis mimicking extensive nodal metastasis from early gastric cancer: A case report. ( 30219658 )
2018
13
Application of data mining methods to improve screening for the risk of early gastric cancer. ( 30526601 )
2018
14
Efficacy of Magnifying Narrow Band Imaging for Delineating Horizontal Margins of Early Gastric Cancer. ( 30423568 )
2018
15
Automatic detection of early gastric cancer in endoscopic images using a transferring convolutional neural network. ( 30441266 )
2018
16
Gastric Xanthoma is a Predictive Marker for Early Gastric Cancer Detected after Helicobacter pylori Eradication. ( 30449773 )
2018
17
Different risk factors between early and late cancer recurrences in patients without additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer. ( 30465769 )
2018
18
Long-term outcome of endoscopic submucosal dissection for early gastric cancer in patients with severe comorbidities: a comparative propensity score analysis. ( 30382467 )
2018
19
Midterm body composition changes after open distal gastrectomy for early gastric cancer. ( 30310802 )
2018
20
Endoscopic Indication of Endoscopic Submucosal Dissection for Early Gastric Cancer Is Not Compatible with Pathologic Criteria in Clinical Practice. ( 30311155 )
2018
21
Effect of gastrectomy on blood pressure in early gastric cancer survivors with hypertension. ( 30317431 )
2018
22
Validation of classic and expanded criteria for endoscopic submucosal dissection of early gastric cancer: 7 years of experience in a Western tertiary cancer center. ( 30328950 )
2018
23
Role of gastroscopic biopsy of gastric ulcer margins and healed sites in the diagnosis of early gastric cancer: A clinical controlled study of 513 cases. ( 30250534 )
2018
24
Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis. ( 30251121 )
2018
25
Safety of expanded criteria for endoscopic resection of early gastric cancer in a Western cohort. ( 30253755 )
2018
26
Sentinel node navigation surgery using near-infrared indocyanine green fluorescence in early gastric cancer. ( 30167947 )
2018
27
Early Gastric Cancer with Diffuse Lanthanum Deposition. ( 30146601 )
2018
28
Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer: sentinel node concept. ( 29799060 )
2018
29
Differentiated-type predominant mixed-histology-type early gastric cancer is a significant risk factor for endoscopic non-curative resection regardless of tumor size. ( 29808612 )
2018
30
A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation. ( 29845571 )
2018
31
The Characteristics, Prognosis, and Risk Factors of Lymph Node Metastasis in Early Gastric Cancer. ( 29853864 )
2018
32
Reevaluation of laparoscopic versus open distal gastrectomy for early gastric cancer in Asia: A meta-analysis of randomized controlled trials. ( 29860125 )
2018
33
The Role of an Undifferentiated Component in Submucosal Invasion and Submucosal Invasion Depth After Endoscopic Submucosal Dissection for Early Gastric Cancer. ( 29870985 )
2018
34
Current status of endoscopic submucosal dissection for early gastric cancer in Korea: role and benefits. ( 29921044 )
2018
35
Laparoscopic subtotal gastrectomy with a new marking technique, endoscopic cautery marking: preservation of the stomach in patients with upper early gastric cancer. ( 29922851 )
2018
36
Deep learning-based endoscopic image recognition for detection of early gastric cancer: a Chinese perspective. ( 29935613 )
2018
37
Long-Term Clinical Efficacy and Safety of Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea. ( 29945421 )
2018
38
Local or extragastric recurrence after incomplete endoscopic submucosal dissection of early gastric cancer: risk factors and the role of CT. ( 29948060 )
2018
39
Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab. ( 29978335 )
2018
40
Feasibility and Safety of Totally Laparoscopic Radical Gastrectomy for Advanced Gastric Cancer: Comparison with Early Gastric Cancer. ( 29984065 )
2018
41
Erratum: Is Lymph Node Size a Reliable Factor for Estimating Lymph Node Metastasis in Early Gastric Cancer? ( 29984071 )
2018
42
Young Age and Risk of Lymph Node Metastasis in Differentiated Type Early Gastric Cancer. ( 30006689 )
2018
43
Early gastric cancer successfully treated by endoscopic submucosal resection 1 year after laparoscopic sleeve gastrectomy with duodenal-jejunal bypass. ( 30015399 )
2018
44
Endoscopic molecular imaging of early gastric cancer using fluorescently labeled human H-ferritin nanoparticle. ( 30056091 )
2018
45
Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. ( 30074155 )
2018
46
Propensity score-matching analysis to compare clinical outcomes of endoscopic submucosal dissection for early gastric cancer in the postoperative and non-operative stomachs. ( 30081824 )
2018
47
Long-term changes in the metabolic and nutritional parameters after gastrectomy in early gastric cancer patients with overweight. ( 30097398 )
2018
48
Potential for local resection with sentinel node basin dissection for early gastric cancer based on the distribution of primary sites. ( 30099636 )
2018
49
Blue Laser Imaging with a Small-Caliber Endoscope Facilitates Detection of Early Gastric Cancer. ( 30103296 )
2018
50
Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer. ( 28639042 )
2018

Variations for Microinvasive Gastric Cancer

Expression for Microinvasive Gastric Cancer

Search GEO for disease gene expression data for Microinvasive Gastric Cancer.

Pathways for Microinvasive Gastric Cancer

Pathways related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.59 CDH1 CDX2 MLH1 MUC2

GO Terms for Microinvasive Gastric Cancer

Biological processes related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium ion transport GO:0006814 9.5 ATP12A ATP4A SCN10A
2 potassium ion import across plasma membrane GO:1990573 9.46 ATP12A ATP4A
3 potassium ion import GO:0010107 9.43 ATP12A ATP4A
4 ATP hydrolysis coupled proton transport GO:0015991 9.4 ATP12A ATP4A
5 resolution of meiotic recombination intermediates GO:0000712 9.37 EME2 MLH1
6 cellular sodium ion homeostasis GO:0006883 9.26 ATP12A ATP4A
7 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.16 ATP12A ATP4A
8 cellular potassium ion homeostasis GO:0030007 8.96 ATP12A ATP4A
9 sodium ion export across plasma membrane GO:0036376 8.62 ATP12A ATP4A

Molecular functions related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 8.96 ATP12A ATP4A
2 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP12A ATP4A

Sources for Microinvasive Gastric Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....